{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:19:04Z","timestamp":1791069544521,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.juro.2013.03.097","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T15:02:56Z","timestamp":1364569376000},"page":"857-862","source":"Crossref","is-referenced-by-count":63,"title":["The Impact of Intravesical Gemcitabine and 1\/3 Dose Bacillus Calmette-Gu\u00e9rin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial"],"prefix":"10.1097","volume":"190","author":[{"given":"Paolo","family":"Gontero","sequence":"first","affiliation":[{"name":"Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Oderda","sequence":"additional","affiliation":[{"name":"Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mehnert","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gurioli","sequence":"additional","affiliation":[{"name":"Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lucca","sequence":"additional","affiliation":[{"name":"Department of Urology-1, University of Turin, A.O.U. San Giovanni Battista, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[{"name":"Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Kluth","sequence":"additional","affiliation":[{"name":"Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pappagallo","sequence":"additional","affiliation":[{"name":"Oncology Unit, Noale Hospital, Noale, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Sogni","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Eastern Piedmont, Maggiore della Carit\u00e0 Hospital, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sanguedolce","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Martorana","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"Department of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Chun","sequence":"additional","affiliation":[{"name":"Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.03.097_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.03.097_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Gu\u00e9rin in the treatment of non-muscle-invasive bladder cancer","volume":"57","author":"Gontero","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.03.097_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.03.097_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.eururo.2004.05.001","article-title":"Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC)","volume":"46","author":"Gontero","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.03.097_bib5","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1200\/JCO.2005.05.2720","article-title":"Phase II trial of intravesical gemcitabine in bacille Calmette-Gu\u00e9rin-refractory transitional cell carcinoma of the bladder","volume":"24","author":"Dalbagni","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2013.03.097_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance","volume":"28","author":"Addeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2013.03.097_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.03.097_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eursup.2007.04.008","article-title":"Treatment of intermediate-risk non-muscle-invasive bladder cancer (NMIBC)","volume":"6","author":"Hendricksen","year":"2007","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.juro.2013.03.097_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.juro.2013.03.097_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2013.03.097_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Int Med"},{"key":"10.1016\/j.juro.2013.03.097_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.urology.2005.09.045","article-title":"Sustained prophylactic effect of intravesical bacille Calmette-Gu\u00e9rin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study","volume":"67","author":"Hinotsu","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.03.097_bib14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000173919.28835.aa","article-title":"Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against the recurrences and progression of T1G3 and Tis bladder tumors than the standard dose?","volume":"174","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2005","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2013.03.097_bib15","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.juro.2011.02.1765","article-title":"Intravesical gemcitabine versus bacillus Calmette-Guerin (BCG) in treatment of non-muscle invasive bladder cancer: short term comparative study","volume":"185","author":"Bendary","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.03.097_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000273461","article-title":"Bacillus Calmette-Gu\u00e9rin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study","volume":"84","author":"Porena","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2013.03.097_bib17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/cncr.24914","article-title":"Gemcitabine versus bacille Calmette-Gu\u00e9rin after initial bacille Calmette-Gu\u00e9rin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial","volume":"116","author":"Di Lorenzo","year":"2010","journal-title":"Cancer"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713038901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713038901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.03.097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:25:32Z","timestamp":1651202732000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.03.097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1016\/j.juro.2013.03.097"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.03.097","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}